Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1286 of 5804
-
AI helps doctors spot cancerous polyps during colonoscopy
Diagnosis CompletedColorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-related death worldwide. Colonoscopy is considered the preferred method of screening for colorectal cancer, and early and resection detection of colorectal neoplastic lesions can si…
Sponsor: The First Hospital of Jilin University • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Preventive radiation may stop bone metastases from causing fractures
Disease control Recruiting nowThe goal of this clinical trial is to learn whether radiotherapy (i.e. treatment with ionizing radiation to destroy cancer cells) can prevent symptoms in patients with metastatic cancer, having high-risk bone metastases that currently result in no or only mild symptoms. High-risk…
Phase: NA • Sponsor: Cancer Research Antwerp • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New radiation technique aims to ease urinary problems in prostate cancer treatment
Symptom relief Recruiting nowThe ASPIRE study is a Phase III randomized, single-center study designed to evaluate whether adaptive stereotactic body radiotherapy (SBRT) offers superior clinical benefits compared to standard image-guided SBRT for patients with localized prostate cancer. It aims to explore whe…
Phase: PHASE3 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New drug cocktail targets Hard-to-Treat cancers
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, drug levels, and preliminary efficacy of BMS-986507 combinations in adult participants with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Smarter radiation: could less be more for throat cancer patients?
Disease control Recruiting nowMulticentric prospective model-based de-escalation of the elective clinical target volumes (CTV) in radiotherapy of oropharyngeal carcinoma of all stages with the goal to reduce toxicity. The study investigates the feasibility of this approach as measured by the number of expect…
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New hope for CLL patients with weak hearts: acalabrutinib under the microscope
Disease control Recruiting nowThis will be a global Phase IV, open-label, randomised study to evaluate the safety and tolerability of acalabrutinib (monotherapy, 100 mg orally \[po\], twice daily \[bd\]) compared to investigator's choice of treatment, in patients with CLL (TN or R/R) and moderate to severe ca…
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug targets tough cancers in early trial
Disease control Recruiting nowThe goal of this clinical trial is to learn if KQB365 works to treat advanced solid tumor cancer in adults. It will also learn about the safety of KQB365. The main questions it aims to answer are: * What is the safe dose of KQB365 by itself, in combination with cetuximab, or in …
Phase: PHASE1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New scan could spot hidden artery disease faster
Diagnosis Recruiting nowThe goal of this open-label clinical trial is to evaluate the efficacy of AzaFol-PET/CT in the diagnosis of GCA (giant cell arteritis), to compare AzaFol- with 2-\[18F\]FDG-PET/CT, and to assess the safety and tolerability of AzaFol in subjects with suspicion of GCA. Participant…
Phase: PHASE2 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
Real-World data shows Tirabrutinib's promise for rare brain cancer
Disease control CompletedThe goal of this observational study is to describe the real-world effectiveness and safety of tirabrutinib among relapsed or refractory PCNSL patients in Taiwan.
Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Real-World lupus study reveals how new drug performs outside clinical trials
Disease control CompletedAZAHAR is an observational retrospective and longitudinal study with adults patients with SLE who initiated treatment with anifrolumab from June 1, 2023 to May 31, 2024. The overall objective is to describe the characteristics and clinical outcomes of patients with SLE that init…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Can better provider training save black and hispanic mothers?
Knowledge-focused Recruiting nowThe goal of the study involving human subjects is to train providers to address patient-provider interactions. The study will survey providers to assess pre-post knowledge, understanding, and behavior changes.
Phase: NA • Sponsor: Michigan State University • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
AI tool aims to match kids with the right mental health care
Knowledge-focused CompletedThe purpose of this study is to test the effectiveness of a new clinical decision support tool, Placement Success Predictor (PSP), in a naturalistic setting. PSP will provide placement-specific predictions about the likelihood of a youth having a good outcome in each placement ty…
Sponsor: Outcome Referrals, Inc. • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
New weekly pill could ease depression symptoms
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if zelquistinel works to treat depression in adults. It will also learn about the safety of zelquistinel. The main questions it aims to answer are: Does zelquistinel reduce depression scores in participants compared to participants who…
Phase: PHASE2 • Sponsor: Syndeio Biosciences, Inc • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
New smart drug targets tough cancers in early human test
Disease control Recruiting nowThis open-label clinical trial will evaluate the safety and tolerability of NN3201 in subjects with advanced and/or metastatic solid tumors known to express c-Kit.
Phase: PHASE1 • Sponsor: Novelty Nobility, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug combo aims to outsmart HER2-Positive cancers
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of azenosertib in combination with trastuzumab deruxtecan in treating patients with HER2-positive gastric or gastroesophageal junction cancer and other HER2-positive solid tumors that have spread to nearby tissue or…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could entresto help adult hearts born with defects?
Disease control Recruiting nowThe purpose of this study is to compare changes in cardiac structure and function, biomarkers, and patient reported outcomes between adults with congenital heart disease (ACHD) randomized to angiotensin receptor-neprilysin inhibitor (ARNI) therapy vs placebo.
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Peer power: HIV Self-Test kits could boost testing in Drug-Using networks
Prevention Recruiting nowHIV testing and service uptake are infrequent among people who use drugs (PWUD) in the United States. In partnership with a community-based syringe service program (SSP), this project will develop the SSP-based "Prevention Ambassadors" (PA) intervention to promote HIV testing and…
Phase: NA • Sponsor: San Diego State University • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Magnetic brain zaps could curb alcohol cravings, new study hopes
Disease control Recruiting nowThis study is testing a new treatment called IR-TMS (image-guided, robot navigated transcranial magnetic stimulation) to see if it can help people who drink too much alcohol to reduce the amount they drink. Participants will be placed into one of three groups, each receiving a sl…
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Exercise and education may ease migraine burden
Symptom relief OngoingThe study project aims to implement therapeutic patient education for migraine, promoting improvement in outpatient clinical practice by providing counseling moments specifically dedicated to known health risk factors (sedentary lifestyle, physical inactivity, unhealthy eating ha…
Phase: NA • Sponsor: Centro Universitario Ricerca Interdipartimentale Attivita' Motoria • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Smartphone app could help breast cancer survivors avoid painful arm swelling
Prevention OngoingBreast cancer is the most common cancer among women in the world and in our country and affects women negatively in many ways. Depending on the treatment, patients experience serious problems. Especially in patients with sentinel lymph node biopsy and axillary lymph node dissecti…
Phase: NA • Sponsor: Inonu University • Aim: Prevention
Last updated Jul 16, 2026 00:00 UTC